Cargando…

Misinformation and Facts about Breast Cancer Screening

Quality medical practice is based on science and evidence. For over a half-century, the efficacy of breast cancer screening has been challenged, particularly for women aged 40–49. As each false claim has been raised, it has been addressed and refuted based on science and evidence. Nevertheless, misi...

Descripción completa

Detalles Bibliográficos
Autor principal: Kopans, Daniel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406995/
https://www.ncbi.nlm.nih.gov/pubmed/36005183
http://dx.doi.org/10.3390/curroncol29080445
_version_ 1784774257764466688
author Kopans, Daniel B.
author_facet Kopans, Daniel B.
author_sort Kopans, Daniel B.
collection PubMed
description Quality medical practice is based on science and evidence. For over a half-century, the efficacy of breast cancer screening has been challenged, particularly for women aged 40–49. As each false claim has been raised, it has been addressed and refuted based on science and evidence. Nevertheless, misinformation continues to be promoted, resulting in confusion for women and their physicians. Early detection has been proven to save lives for women aged 40–74 in randomized controlled trials of mammography screening. Observational studies, failure analyses, and incidence of death studies have provided evidence that there is a major benefit when screening is introduced to the general population. In large part due to screening, there has been an over 40% decline in deaths from breast cancer since 1990. Nevertheless, misinformation about screening continues to be promoted, adding to the confusion. Despite claims to the contrary, a careful reading of the guidelines issued by major groups such as the U.S. Preventive Services Task Force and the American College of Physicians shows that they all agree that most lives are saved by screening starting at the age of 40. There is no scientific support for using the age of 50 as a threshold for screening. All women should be provided with the facts and not false information about breast cancer screening so that they can make “informed decisions” for themselves about whether to participate.
format Online
Article
Text
id pubmed-9406995
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94069952022-08-26 Misinformation and Facts about Breast Cancer Screening Kopans, Daniel B. Curr Oncol Commentary Quality medical practice is based on science and evidence. For over a half-century, the efficacy of breast cancer screening has been challenged, particularly for women aged 40–49. As each false claim has been raised, it has been addressed and refuted based on science and evidence. Nevertheless, misinformation continues to be promoted, resulting in confusion for women and their physicians. Early detection has been proven to save lives for women aged 40–74 in randomized controlled trials of mammography screening. Observational studies, failure analyses, and incidence of death studies have provided evidence that there is a major benefit when screening is introduced to the general population. In large part due to screening, there has been an over 40% decline in deaths from breast cancer since 1990. Nevertheless, misinformation about screening continues to be promoted, adding to the confusion. Despite claims to the contrary, a careful reading of the guidelines issued by major groups such as the U.S. Preventive Services Task Force and the American College of Physicians shows that they all agree that most lives are saved by screening starting at the age of 40. There is no scientific support for using the age of 50 as a threshold for screening. All women should be provided with the facts and not false information about breast cancer screening so that they can make “informed decisions” for themselves about whether to participate. MDPI 2022-08-09 /pmc/articles/PMC9406995/ /pubmed/36005183 http://dx.doi.org/10.3390/curroncol29080445 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Kopans, Daniel B.
Misinformation and Facts about Breast Cancer Screening
title Misinformation and Facts about Breast Cancer Screening
title_full Misinformation and Facts about Breast Cancer Screening
title_fullStr Misinformation and Facts about Breast Cancer Screening
title_full_unstemmed Misinformation and Facts about Breast Cancer Screening
title_short Misinformation and Facts about Breast Cancer Screening
title_sort misinformation and facts about breast cancer screening
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406995/
https://www.ncbi.nlm.nih.gov/pubmed/36005183
http://dx.doi.org/10.3390/curroncol29080445
work_keys_str_mv AT kopansdanielb misinformationandfactsaboutbreastcancerscreening